0001209191-20-003283.txt : 20200114
0001209191-20-003283.hdr.sgml : 20200114
20200114160629
ACCESSION NUMBER: 0001209191-20-003283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200110
FILED AS OF DATE: 20200114
DATE AS OF CHANGE: 20200114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legault Pierre
CENTRAL INDEX KEY: 0001391045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20526122
MAIL ADDRESS:
STREET 1: P.O. BOX 1028
STREET 2: C/O STONE MANAGEMENT LLC
CITY: BERWYNE
STATE: PA
ZIP: 19312
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-10
0
0001740547
Urovant Sciences Ltd.
UROV
0001391045
Legault Pierre
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVENUE, SUITE 100
IRVINE
CA
92617
1
0
0
0
Common Shares
2020-01-10
4
A
0
12480
0.00
A
12480
D
The Restricted Stock Units shall vest on January 10, 2021, subject to the Reporting Person providing continuous service to the Issuer through such vesting date.
/s/Bryan Smith, Attorney-in-Fact
2020-01-14